Soyeon Ko
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Erratum to "Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies" [Biomol Ther 32(6), 708-722 (2024)].
Journal: Biomolecules & therapeutics
Published: October 31, 2025
CD44-targeted RIP3 gene delivery strategy for enhanced cancer therapy via necroptosis and immune modulation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 12, 2025
Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies.
Journal: Biomolecules & therapeutics
Published: August 21, 2024
Repositioning of aripiprazole, an anti‑psychotic drug, to sensitize the chemotherapy of pancreatic cancer.
Journal: International journal of molecular medicine
Published: August 08, 2024
Lidocaine combined with general anesthetics impedes metastasis of breast cancer cells via inhibition of TGF-β/Smad-mediated EMT signaling by reprogramming tumor-associated macrophages.
Journal: International immunopharmacology
Published: April 17, 2024
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation.
Journal: Nature communications
Published: October 05, 2023
Synergistic Renoprotective Effect of Melatonin and Zileuton by Inhibition of Ferroptosis via the AKT/mTOR/NRF2 Signaling in Kidney Injury and Fibrosis.
Journal: Biomolecules & therapeutics
Published: March 23, 2023
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 12, 2023
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer.
Journal: American journal of cancer research
Published: July 31, 2022
Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancer.
Journal: American journal of cancer research
Published: April 04, 2022
Discovery of a novel NUAK1 inhibitor against pancreatic cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 15, 2021
ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a.
Journal: EMBO molecular medicine
Published: July 29, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026